Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-02-24 Annual Report (ESEF)
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
ucbsa-2021-12-31 (FR).zip
Annual Report (ESEF) Classification · 1% confidence FY 2021
2022-02-24 French
ucbsa-2021-12-31.html
Annual Report Classification · 1% confidence The document is titled 'Rapport Annuel Intégré 2021' (Integrated Annual Report 2021) for UCB. It contains comprehensive sections including management reports, financial performance, governance, and sustainability data. It is clearly the full annual report rather than an announcement or a summary, as it includes detailed financial statements, audit references, and extensive business analysis for the fiscal year 2021. FY 2021
2022-02-24 French
ucbsa-2021-12-31.html
Annual Report Classification · 1% confidence The document is titled 'Geïntegreerd jaarverslag 2021' (Integrated Annual Report 2021) for UCB. It contains comprehensive financial data, management reports, governance statements, and performance metrics for the full fiscal year 2021. It is clearly the primary annual reporting document, not an announcement or a summary, and fits the definition of an Annual Report (10-K equivalent for non-US entities). FY 2021
2022-02-24 Dutch
ucbsa-2021-12-31 (NL).zip
Annual Report (ESEF) Classification · 1% confidence FY 2021
2022-02-24 Dutch
220218 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Disposal of own shares' and details a transaction where UCB disposed of 3,100 shares OTC on February 17, 2022, related to the exercise of stock options under the Long-Term Incentive Program. This directly relates to the company managing its own equity by transacting its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and contains the transaction details, not just an announcement of a report.
2022-02-18 English
220218 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and explicitly states that the company (UCB SA) alienated (sold/transferred) 3,100 UCB shares following the exercise of options by personnel, related to long-term variable compensation. This action involves the company dealing in its own shares, which directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. The document is short and appears to be a regulatory disclosure of this specific transaction.
2022-02-18 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.